[1] 章振林,金小岚,夏维波.原发性骨质疏松症诊疗指南(2017版)要点解读[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):411-412.
[2] 赵宗权,吴贻红,汤振源,等.老年骨质疏松症流行病学调查及预防措施研究[J].中国骨质疏松杂志,2019,25(7):994-997.
[3] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019, 12(4):317-318.
[4] 朱洁云,高敏,宋秋韵,等.中国老年人骨质疏松症患病率的 Meta 分析[J].中国全科医学,2022,25(3):346-353.
[5] 谈志龙,任海龙,白人骁,等.骨质疏松症与骨代谢生化测定指标[J].中国骨质疏松杂志,2006,12(1):89-93.
[6] DENG Q, LI P, CHE M, et al. Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin. Elife. 2019;8:e50208.
[7] 郭强,于冬冬.基于代谢组学技术探讨中医药防治骨质疏松症的研究进展[J].广西中医药,2022,45(5):67-70.
[8] 谢宝辉,罗礼亮,巫远华.阿仑膦酸钠联合中药及理疗治疗骨质疏松症的临床效果[J].中国当代医药,2020,27(15):100-102.
[9] 佟喆,张振南,于潼.运动疗法防治骨质疏松症机制的研究进展[J].中国骨质疏松杂志,2022,28(10):1556-1560.
[10] CHEN X, LI L, GUO J, et al. Treadmill running exercise prevents senile osteoporosis and upregulates the Wnt signaling pathway in SAMP6 mice. Oncotarget. 2016; 7(44):71072-71086.
[11] LIU DB, SUI C, WU TT, et al. Association of Bone Morphogenetic Protein (BMP)/Smad Signaling Pathway with Fracture Healing and Osteogenic Ability in Senile Osteoporotic Fracture in Humans and Rats. Med Sci Monit. 2018;24:4363-4371.
[12] XUN J, LI C, LIU M, et al. Serum exosomes from young rats improve the reduced osteogenic differentiation of BMSCs in aged rats with osteoporosis after fatigue loading in vivo. Stem Cell Res Ther. 2021;12(1):424.
[13] MA S, QIN J, HAO Y, et al. Association of gut microbiota composition and function with an aged rat model of senile osteoporosis using 16S rRNA and metagenomic sequencing analysis. Aging. 2020;12(11):10795-10808.
[14] DURDAN MM, AZARIA RD, WEIVODA MM. Novel insights into the coupling of osteoclasts and resorption to bone formation. Semin Cell Dev Biol. 2022;123:4-13.
[15] WALKER EC, MCGREGOR NE, POULTON IJ, et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest. 2010;120(2):582-592.
[16] CHANDRA A, RAJAWAT J. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. Int J Mol Sci. 2021;22(7):3553.
[17] KHOSLA S, FARR JN, MONROE DG. Cellular senescence and the skeleton: pathophysiology and therapeutic implications. J Clin Invest. 2022;132(3):e154888.
[18] IVASKA KK, MCGUIGAN FE, MALMGREN L, et al. Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90. Calcif Tissue Int. 2022. doi:10.1007/s00223-022-00996-8.
[19] NIIMI R, CHIBA K, OKAZAKI N, et al. Relationships between QUS and HR-pQCT, DXA, and bone turnover markers. J Bone Miner Metab, 2022.doi:10.1007/s00774-022-01346-2.
[20] ATALAY S, ELCI A, KAYADIBI H, et al. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med. 2012;32(1):23-30.
[21] REMPE J, ROSENGREN BE, JEHPSSON L, et al. Physical Activity in Late Prepuberty and Early Puberty Is Associated With High Bone Formation and Low Bone Resorption. Front Physiol. 2022;13:828508.
[22] BUCK DW 2ND, DUMANIAN GA. Bone biology and physiology: Part II. Clinical correlates. Plast Reconstr Surg. 2012;129(6):950e-956e.
[23] COOPER LF, MASUDA T, YLIHEIKKILÄ PK, et al. Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies. Int J Oral Maxillofac Implants. 1998;13(2):163-174.
[24] BUCK DW 2ND, DUMANIAN GA. Bone biology and physiology: Part I. The fundamentals. Plast Reconstr Surg. 2012;129(6):1314-1320.
[25] VASIKARAN SD, MIURA M, PIKNER R, et al. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis. Calcif Tissue Int. 2023;112(2):148-157.
[26] ANAM AK, INSOGNA K. Update on Osteoporosis Screening and Management. Med Clin North Am. 2021;105(6):1117-1134.
[27] SHEVROJA E, CAFARELLI FP, GUGLIELMI G, et al. DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine. 2021;74(1):20-28.
[28] KANAZAWA M, MATSUMOTO Y, TAKAHASHI K, et al. Treadmill exercise prevents reduction of bone mineral density after myocardial infarction in apolipoprotein E-deficient mice. Eur J Prev Cardiol. 2020;27(1):28-35.
[29] GAO L, LI Y, YANG YJ, et al. The Effect of Moderate-Intensity Treadmill Exercise on Bone Mass and the Transcription of Peripheral Blood Mononuclear Cells in Ovariectomized Rats. Front Physiol. 2021;12:729910.
[30] LIU J, XIAO Q, XIAO J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.
[31] YUAN X, LIU H, HUANG H, et al. The Key Role of Canonical Wnt/β-catenin Signaling in Cartilage Chondrocytes. Curr Drug Targets. 2016;17(4):475-484.
[32] BARTOLETTI G, DONG C, UMAR M, et al. Pdgfra regulates multipotent cell differentiation towards chondrocytes via inhibiting Wnt9a/beta-catenin pathway during chondrocranial cartilage development. Dev Biol. 2020;466(1-2):36-46.
[33] JING Y, JING J, WANG K, et al. Vital Roles of β-catenin in Trans-differentiation of Chondrocytes to Bone Cells. Int J Biol Sci. 2018;14(1):1-9.
[34] CHAN BY, LITTLE CB. The interaction of canonical bone morphogenetic protein- and Wnt-signaling pathways may play an important role in regulating cartilage degradation in osteoarthritis. Arthritis Res Ther. 2012;14(3):119.
[35] SPENCER GJ, UTTING JC, ETHERIDGE SL, et al. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci. 2006;119(Pt 7):1283-1296.
[36] ROSSINI M, GATTI D, ADAMI S. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int. 2013;93(2):121-132.
[37] LETTINI G, CONDELLI V, PIETRAFESA M, et al. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation. Int J Mol Sci. 2020;21(20):7526.
[38] HUANG Y, LIU L, LIU A. Dickkopf-1: Current knowledge and related diseases. Life Sci. 2018;209:249-254.
[39] CHIARITO M, PIACENTE L, CHAOUL N, et al. Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome. J Endocrinol Invest. 2022;45(6):1255-1263.
[40] ZHANG Y, SHI T, HE Y. GPR35 regulates osteogenesis via the Wnt/GSK3β/β-catenin signaling pathway. Biochem Biophys Res Commun. 2021;556:171-178.
[41] KARIM K, GIRIBABU N, SALLEH N. Marantodes pumilum (blume) Kuntze (Kacip Fatimah) leaves aqueous extract prevents downregulation of Wnt/β-catenin pathway and upregulation of apoptosis in osteoblasts of estrogen-deficient, diabetes-induced rats. J Ethnopharmacol. 2021;280:114236.
[42] LIANG L, TU Y, LU J, et al. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway. J Cell Sci. 2019;132(10):jcs228478.
[43] LAW SM, ZHENG JJ. Premise and peril of Wnt signaling activation through GSK-3β inhibition. iScience. 2022;25(4):104159.
[44] MAROSI M, ARMAN P, ACETO G, et al. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases. Int J Mol Sci. 2022;23(8):4413.
[45] BARON R, KNEISSEL M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179-192.
[46] ZHAO SJ, KONG Q, JIE J, et al. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3β/β-catenin pathway. Theranostics. 2020;10(1):17-35.
[47] LARA-CASTILLO N, JOHNSON ML. LRP receptor family member associated bone disease. Rev Endocr Metab Disord. 2015;16(2):141-148.
[48] SANTOS L, UGUN-KLUSEK A, COVENEY C, et al. Multiomic analysis of stretched osteocytes reveals processes and signalling linked to bone regeneration and cancer. NPJ Regen Med. 2021;6(1):32.
[49] MOVéRARE-SKRTIC S, HENNING P, LIU X, et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med. 2014;20(11):1279-1288.
[50] TONG X, CHEN X, ZHANG S, et al. The Effect of Exercise on the Prevention of Osteoporosis and Bone Angiogenesis. Biomed Res Int. 2019;2019:8171897.
|